Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep;234(9):15678-15685.
doi: 10.1002/jcp.28219. Epub 2019 Jan 31.

HIV-1 Tat protein induces aberrant activation of AICDA in human B-lymphocytes from peripheral blood

Affiliations

HIV-1 Tat protein induces aberrant activation of AICDA in human B-lymphocytes from peripheral blood

Fatimata Bintou Sall et al. J Cell Physiol. 2019 Sep.

Abstract

Individuals infected with human immunodeficiency virus (HIV) are at increased risk for Burkitt lymphoma, a B-cell malignancy which occurs after a chromosomal translocation rearranging the MYC oncogene with an immunoglobulin gene locus, usually the IGH heavy chain gene locus. We have previously reported that the HIV protein Tat which circulates in all HIV-positive individuals whatever their immune status caused an increased rate of colocalization between IGH and MYC in B-cells nuclei. We here present in vitro evidence that Tat activates the expression of the AICDA gene that encodes the activation-induced cytidine deaminase whose physiological function is to create double-strand breaks for immunoglobulin gene maturation. In the presence of Tat, DNA damage was observed concomitantly in both MYC and IGH, followed by DNA repair by nonhomologous end joining. AICDA was further found overexpressed in vivo in peripheral blood B-cells from HIV-infected individuals. Thus, the capacity of Tat to spontaneously penetrate B-cells could be sufficient to favor the occurrence of MYC-IGH oncogenic rearrangements during erroneous repair, a plausible cause for the increased incidence of Burkitt lymphoma in the HIV-infected population.

Keywords: B-cell; IGH; activation-induced cytidine deaminase (AID); human immunodeficiency virus-1 (HIV-1) Tat; oncogenesis.

PubMed Disclaimer

References

REFERENCES
    1. Allinne, J., Pichugin, A., Iarovaia, O., Klibi, M., Barat, A., Zlotek-Zlotkiewicz, E., … Vassetzky, Y. S. (2014). Perinucleolar relocalization and nucleolin as crucial events in the transcriptional activation of key genes in mantle cell lymphoma. Blood, 123(13), 2044-2053. https://doi.org/10.1182/blood-2013-06-510511
    1. Chandra, V., Bortnick, A., & Murre, C. (2015). AID targeting: Old mysteries and new challenges. Trends in Immunology, 36, 527-535. https://doi.org/10.1016/j.it.2015.07.003
    1. Clifford, G. M., Polesel, J., Rickenbach, M., Dal maso, L., Keiser, O., Kofler, A., … Franceschi, S. (2005). Cancer risk in the Swiss HIV cohort study: Associations with immunodeficiency, smoking, and highly active antiretroviral therapy. Journal of the National Cancer Institute, 97, 425-432. https://doi.org/10.1093/jnci/dji072
    1. Cobucci, R. N. O., Lima, P. H., de Souza, P. C., Costa, V. V., Cornetta, M., Cornetta, Mda, & Gonçalves, A. K. (2015). Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: A systematic review. Journal of Infection and Public Health, 8(1) https://doi.org/10.1016/j.jiph.2014.08.003
    1. Dolcetti, R., Gloghini, A., Caruso, A., & Carbone, A. (2016). A lymphomagenic role for HIV beyond immune suppression? Blood, 127(11), 1403-1409. https://doi.org/10.1182/blood-2015-11-681411

LinkOut - more resources